Oxford University Covid-19 vaccine ‘encouraging' for older age groups

Credit: IndiaTimes- Published on November 19, 2020
The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age. The findings published in ‘Lancet' on Thursday based on 560 healthy adult volunteers shows that the ChAdOx1 nCoV-19 vaccine is “safe and well...

Video credit: ABC Action News
Published on November 19, 2020 -  00:35
Oxford University vaccine results show strong immune response in older demographic
Oxford University this morning announced more promising news in the development of its COVID-19 vaccine. The results from Phase 2 of its AZD122 vaccine trial, published in the Lancet on Thursday, show that the vaccine is as effective for the older demographic as it is for the younger. Story: https://wfts.tv/3pM5mAe

You are here


💡 newsR Knowledge: Other News Mentions



The Lancet

Peer-reviewed general medical journal
India's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the..
Credit: IndiaTimes - Published 14 hours ago

Even as a controversy rages over the safety of India’s first indigenous Covid-19 vaccine Covaxin after it was granted Emergency Use Authorisation (EUA) even as..
Credit: IndiaTimes - Published 19 hours ago


Related videos from verified sources

AstraZeneca, 3rd Major COVID-19 Vaccine, Shown to Be Effective and Cheaper 01:10
Credit: Wibbitz Top Stories - Published on November 23, 2020 


How AstraZeneca COVID-19 Vaccine Compares To Moderna, Pfizer 02:09
Credit: WBZ CBS Boston - Published on November 23, 2020 


Virologist welcomes news of 70% efficacy for Oxford vaccine 01:10
Credit: PA - Press Association STUDIO - Published on November 23, 2020 


Related news from verified sources

The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged 56-69 and those...
on November 19, 2020 • IndiaTimes

The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged 56-69 and those...
on November 20, 2020 • Mid-Day

You might like